Teletherapy for treating stammering in adults
Effects of Tele Speech Therapy on the Treatment of Stammering in Adults Who Stutter
This study tests if online speech therapy can help adults who stutter improve their speech better than regular in-person therapy.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 16 (estimated) |
| Ages | 15 Years to 40 Years |
| Sex | All |
| Sponsor | Riphah International University Academic / other |
| Locations | 1 site (Lahore, Punjab) |
| Trial ID | NCT06937437 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the effectiveness of telespeech therapy in treating adults who stutter. Participants will receive teletherapy sessions designed to address their stammering, comparing the outcomes to traditional speech therapy methods. The study will include adults aged 15 to 40 who meet specific criteria for stuttering, while excluding those with additional impairments. The goal is to assess whether remote therapy can provide significant benefits in managing stammering.
Who should consider this trial
Good fit: Ideal candidates are adults aged 15 to 40 who experience stuttering without any comorbid conditions.
Not a fit: Patients with stammering accompanied by visual or hearing impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could offer a convenient and effective treatment option for adults struggling with stammering.
How similar studies have performed: While there is limited data on telespeech therapy specifically for stammering, similar teletherapy approaches have shown promise in other speech-related conditions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Both Genders * Adults With stuttering 15 to 40 years according to WHO criteria Exclusion Criteria: - Stammering with any comorbid are excluded eg. Visual and Hearing Impairment
Where this trial is running
Lahore, Punjab
- Muaz Medical Complex — Lahore, Punjab, Pakistan (Recruiting)
Study contacts
- Principal investigator: Mamona Riaz, M.S — Riphah International University
- Study coordinator: Imran Amjad, PhD
- Email: imran.amjad@riphah.edu.pk
- Phone: 03324390125
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.